• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy for venous thromboembolic disease.

作者信息

Hyers T M, Agnelli G, Hull R D, Weg J G, Morris T A, Samama M, Tapson V

机构信息

Occupational Medicine and Pulmonary Diseases, St. Louis, MO 63122, USA.

出版信息

Chest. 1998 Nov;114(5 Suppl):561S-578S. doi: 10.1378/chest.114.5_supplement.561s.

DOI:10.1378/chest.114.5_supplement.561s
PMID:9822063
Abstract
摘要

相似文献

1
Antithrombotic therapy for venous thromboembolic disease.
Chest. 1998 Nov;114(5 Suppl):561S-578S. doi: 10.1378/chest.114.5_supplement.561s.
2
[Evidence-based guidelines for prevention and therapy of venous thromboembolism].[静脉血栓栓塞症预防与治疗的循证指南]
Minerva Cardioangiol. 2000 Dec;48(12 Suppl 1):27-35.
3
[Anticoagulation in patients with venous thromboembolism].[静脉血栓栓塞症患者的抗凝治疗]
Ther Umsch. 2003 Jan;60(1):43-7. doi: 10.1024/0040-5930.60.1.43.
4
[Treatment of pulmonary thromboembolism with low molecular weight heparin].低分子量肝素治疗肺血栓栓塞症
An Med Interna. 1995 Oct;12(10):515-6.
5
Antithrombotic therapy for venous thromboembolic disease.静脉血栓栓塞性疾病的抗栓治疗。
Chest. 1992 Oct;102(4 Suppl):408S-425S. doi: 10.1378/chest.102.4_supplement.408s.
6
Antithrombotic therapy for venous thromboembolism.
Clin Chest Med. 1984 Sep;5(3):479-86.
7
Antithrombotic therapy for venous thromboembolic disease.静脉血栓栓塞性疾病的抗栓治疗。
Chest. 1986 Feb;89(2 Suppl):26S-35S. doi: 10.1378/chest.89.2_supplement.26s.
8
Venous thromboembolism.静脉血栓栓塞症
BMJ. 2006 Jan 28;332(7535):215-9. doi: 10.1136/bmj.332.7535.215.
9
Antithrombotic therapy for venous thromboembolic disease.静脉血栓栓塞性疾病的抗栓治疗
Chest. 2001 Jan;119(1 Suppl):176S-193S. doi: 10.1378/chest.119.1_suppl.176s.
10
[Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism].[关于欧洲心脏病学会肺栓塞特别工作组指南的评论]
Ital Heart J Suppl. 2001 Dec;2(12):1342-56.

引用本文的文献

1
Poly-ion complex (PIC) formation of heparin and polyamines: PIC with tetrakis (3-aminopropyl) ammonium allows sustained release of heparin.肝素与多胺的聚离子复合物（PIC）形成：与四（3-氨丙基）铵形成的PIC可使肝素持续释放。
Heliyon. 2020 Oct;6(10):e05168. doi: 10.1016/j.heliyon.2020.e05168. Epub 2020 Oct 6.
2
Use and Removal of Inferior Vena Cava Filters in Patients With Acute Brain Injury.急性脑损伤患者下腔静脉滤器的使用与取出
Neurohospitalist. 2020 Jul;10(3):188-192. doi: 10.1177/1941874420907531. Epub 2020 Feb 28.
3
Anti-coagulation Drug Warfarin Contributes to Severe Adverse Outcomes in Prolonged Unsupervised Use: A Double-edged Sword.
抗凝药物华法林在长期无人监管使用时会导致严重不良后果：一把双刃剑。
Cureus. 2018 Sep 22;10(9):e3347. doi: 10.7759/cureus.3347.
4
Effect of pathological heterogeneity on shear wave elasticity imaging in the staging of deep venous thrombosis.病理异质性对深静脉血栓形成分期中剪切波弹性成像的影响。
PLoS One. 2017 Jun 14;12(6):e0179103. doi: 10.1371/journal.pone.0179103. eCollection 2017.
5
Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review.达比加群与华法林治疗急性静脉血栓栓塞的比较：系统评价
Iran J Pharm Res. 2016 Spring;15(2):611-7.
6
Incidence and risk factors for venous thromboembolism following surgical treatment of fractures below the hip: a meta-analysis.髋部以下骨折手术治疗后静脉血栓栓塞的发生率及危险因素：一项荟萃分析。
Int Wound J. 2016 Dec;13(6):1359-1371. doi: 10.1111/iwj.12533. Epub 2016 Mar 2.
7
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.肝素抗凝剂治疗静脉血栓栓塞症的实际管理指南。
J Thromb Thrombolysis. 2016 Jan;41(1):165-86. doi: 10.1007/s11239-015-1315-2.
8
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.加拿大癌症患者静脉血栓栓塞管理共识推荐。第2部分：治疗
Curr Oncol. 2015 Apr;22(2):144-55. doi: 10.3747/co.22.2587.
9
Neuroprotective effect of 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside against sodium nitroprusside-induced neurotoxicity in HT22 cells.2-(4-甲氧基苯基)乙基-2-乙酰氨基-2-脱氧-β-D-吡喃糖苷对 HT22 细胞中亚硝基亚铁氰化钠诱导的神经毒性的神经保护作用。
Mol Cell Biochem. 2013 Nov;383(1-2):149-59. doi: 10.1007/s11010-013-1763-y. Epub 2013 Jul 20.
10
Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.染色体 16 VKORC1 基因组区域的正选择导致了人类抗凝反应的可变性。
PLoS One. 2012;7(12):e53049. doi: 10.1371/journal.pone.0053049. Epub 2012 Dec 28.